Thomas Jefferson University

Thomas Jefferson University, operating as Sidney Kimmel Medical College, is a non-profit private academic medical center and research institution based in Philadelphia that receives federal funding as a prime recipient for medical education, clinical services, and biomedical research grants—delivered across 87% of recent awards as a prime recipient and 13% as a subcontractor to other research institutions.

The institution's federal footprint centers on research grants and medical education contracts. Its primary revenue stream comes from the National Institutes of Health, which accounts for approximately 49% of awards by count. Within NIH, the National Institute of Allergy and Infectious Diseases leads by dollar value ($27 million combined potential), followed by subcontracts to the VA's Veterans Integrated Service Network 4 for clinical dermatology services ($7.6 million) and the Department of the Navy's Bureau of Medicine and Surgery for military medical education ($6.9 million). Recent representative work includes $1.66 million for neuroendocrine prostate cancer research (National Cancer Institute), $1.35 million for immune and targeted melanoma therapies (Defense Health Agency), $2.46 million for G-protein-coupled receptor research in asthma (National Heart, Lung, and Blood Institute), and $813 thousand for trained immunity mechanisms induced by mRNA-LNP vaccines (National Institute of Allergy and Infectious Diseases). Military medical education tuition contracts with the Navy's Bureau of Medicine and Surgery and affiliate dermatology services to Veterans Health Administration represent routine clinical service delivery ($179 thousand to $340 thousand per order).

Customer concentration is moderate: the top five federal agencies account for roughly 49% of awards by count, but the dollar concentration is notably higher at 71%, reflecting the magnitude of large research grants from NIH institutes. The Department of Veterans Affairs, Department of the Navy, and multiple NIH institutes dominate the customer set. The institution does not compete under small-business set-asides; all awards are full-and-open competition or non-competitive clinical service delivery.

Thomas Jefferson University maintains prime positions on two major Navy delivery-order vehicles: Indefinite Delivery Contract N0014098G2462 (76 task orders, $7 million) and Basic Ordering Agreement N0060085G1731 (23 task orders). These represent tuition and fees for military medical education. Activity has grown sharply—from 63 awards in 2022 to 130 in 2024—with a moderation to 80 awards in 2025 and 43 year-to-date in 2026. Within the next twenty-four months, 120 awards (combined potential value $27.4 million) reach ultimate completion and face recompete.

The institution is structured as a parent entity with four named subsidiaries: Jefferson Health Corporation, Kennedy Health System, Albert Einstein Medical Center, and Philadelphia University. The corporate structure reflects a large integrated health system spanning clinical operations, education, and research. The source data classify Thomas Jefferson University as a college/university education provider, with secondary categorization as a physician office and hospital. SCI-reportable federal service contracts above the $150 thousand reporting threshold show $11.5 million in invoiced revenue in FY2022 with minimal subsequent SCI capture (likely because the institution's federal work is predominantly research grants and tuition contracts, which fall outside SCI's scope).

Research capability spans biomedical sciences with emphasis on cancer biology (lymphomas, melanoma, breast cancer, prostate cancer), cardiovascular and pulmonary disease, neurodegenerative disorders (ALS, Alzheimer's disease), infectious disease (HIV, Chlamydia, influenza), immunology, and translational medicine. The institution operates the Sidney Kimmel Cancer Center (an NCI-designated comprehensive cancer center), the Comprehensive Epilepsy Center, and multiple research cores supporting NIH-funded work. Federal grant recipients include the institution as prime recipient and named universities (University of Pennsylvania, University of Pittsburgh, University of Maryland Baltimore, Rutgers, and others) as sub-recipients in multi-site consortium arrangements, indicating Thomas Jefferson's role as both research leader and collaborating site in complex, federally-funded multi-institutional investigations.